R69* (p.Arg69Ter) variant of KRT4 (Keratin, type II cytoskeletal 4)

R69* (p.Arg69Ter) in KRT4 (Keratin, type II cytoskeletal 4) is a protein-truncating change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.44 / 1. The record also includes population frequency data and structural context.

R69* (p.Arg69Ter) variant details